Compounds have been manually associated with targets based on literature curation (Curated), and transitively associated with known druggable homologs or direct orthologs (predicted). Network derived target prioritizations also allows to convert any gene list into a drug list by making use of gene-drug indirect relationships within the repurposing network. All associations are done with true positives (known druggable targets), but predicted interactions are by no means tested or experimentally validated.
4110 records found | Showing page 165 of 165 (records 4101-4110) | Number of records to display | Find orthologs in
Organism | Name | Ortholog group | Product |
---|---|---|---|
T. cruzi | TcCLB.511907.130 | OG5_132223 | mucin-like glycoprotein, putative |
T. cruzi | TcCLB.511907.230 | OG5_128882 | folate-binding protein YgfZ, putative |
T. cruzi | TcCLB.511907.40 | OG5_162372 | hypothetical protein, conserved |
T. cruzi | TcCLB.511909.20 | No group | expression site-associated gene 3 (ESAG3-like) protein, putative |
T. cruzi | TcCLB.511909.30 | OG5_151711 | hypothetical protein, conserved |
T. cruzi | TcCLB.511909.50 | OG5_168153 | hypothetical protein, conserved |
T. cruzi | TcCLB.511909.70 | OG5_145814 | hypothetical protein, conserved |
T. cruzi | TcCLB.511911.90 | OG5_128854 | hypothetical protein, conserved |
T. cruzi | TcCLB.511921.140 | OG5_126552 | Mucin-associated surface protein (MASP), subgroup S121 |
T. cruzi | TcCLB.511923.120 | No group | dihydroorotate dehydrogenase, putative |